PMID- 11490367 OWN - NLM STAT- MEDLINE DCOM- 20010906 LR - 20131121 IS - 0039-6060 (Print) IS - 0039-6060 (Linking) VI - 130 IP - 2 DP - 2001 Aug TI - Nitric oxide mediates dendritic cell apoptosis by downregulating inhibitors of apoptosis proteins and upregulating effector caspase activity. PG - 326-32 AB - BACKGROUND: Dendritic cells (DCs) play a crucial role in the amplification of the immune response by promoting antigen presentation, T-lymphocyte proliferation, and proinflammatory cytokine and nitric oxide (NO) production. We have previously shown that the exogenous NO donor, s-nitroso-N-acetyl-penicillamine, promotes DC apoptosis by disrupting the mitochondrial membrane potential, which induces cytochrome-C release and activates caspase 3. To further elucidate the signaling pathway, we examined the expression of cellular inhibitors of apoptosis proteins (cIAPs) and poly (ADP-ribose) polymerase cleavage (PARP), a terminal event in the apoptotic cascade. METHODS: DC2.4 were exposed to 250 micromol/L s-nitroso-N-acetyl-penicillamine for various intervals. Apoptosis and necrosis were measured by terminal deoxynucleotidyl transferase nick-end labeling assay or flow cytometry with Annexin V and propidium iodide. DC2.4 were cultured with the pan-caspase inhibitor, ZVAD (100 micromol/L). cIAP, pro-caspases, and PARP expression or activation was measured by Western blot. Caspase enzyme activity was confirmed with the use of specific substrates. RESULTS: NO-induced DC apoptosis correlated with the downregulation of cIAP expression. Caspase 3 and 6 were upregulated by SNAP and significantly inhibited by ZVAD. Maximal PARP cleavage occurred at 8 hours and coincided with the downregulation of cIAP and peak caspase 3 and near maximal caspase 6 activity. CONCLUSIONS: NO-induced DC apoptosis is associated with the downregulation of cIAP expression, which facilitates caspase cascade activation and subsequent PARP cleavage. FAU - Stanford, A AU - Stanford A AD - Department of Surgery, Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. FAU - Chen, Y AU - Chen Y FAU - Zhang, X R AU - Zhang XR FAU - Hoffman, R AU - Hoffman R FAU - Zamora, R AU - Zamora R FAU - Ford, H R AU - Ford HR LA - eng GR - R01-AI-14032/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Surgery JT - Surgery JID - 0417347 RN - 0 (Amino Acid Chloromethyl Ketones) RN - 0 (Cysteine Proteinase Inhibitors) RN - 0 (Nitric Oxide Donors) RN - 0 (S-nitro-N-acetylpenicillamine) RN - 0 (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 2.4.2.30 (Poly(ADP-ribose) Polymerases) RN - EC 3.4.22.- (Casp3 protein, mouse) RN - EC 3.4.22.- (Casp6 protein, mouse) RN - EC 3.4.22.- (Caspase 3) RN - EC 3.4.22.- (Caspase 6) RN - EC 3.4.22.- (Caspases) RN - GNN1DV99GX (Penicillamine) SB - IM MH - Amino Acid Chloromethyl Ketones/pharmacology MH - Animals MH - Apoptosis/*immunology MH - Bone Marrow Cells/cytology MH - Caspase 3 MH - Caspase 6 MH - Caspases/*metabolism MH - Cell Line, Transformed MH - Cell Survival/immunology MH - Cysteine Proteinase Inhibitors/pharmacology MH - Dendritic Cells/*cytology/immunology/metabolism MH - Down-Regulation/immunology MH - Enzyme Activation/drug effects MH - In Situ Nick-End Labeling MH - Mice MH - Nitric Oxide/*metabolism MH - Nitric Oxide Donors/pharmacology MH - Penicillamine/analogs & derivatives/pharmacology MH - Poly(ADP-ribose) Polymerases/metabolism MH - Up-Regulation/immunology EDAT- 2001/08/08 10:00 MHDA- 2001/09/08 10:01 CRDT- 2001/08/08 10:00 PHST- 2001/08/08 10:00 [pubmed] PHST- 2001/09/08 10:01 [medline] PHST- 2001/08/08 10:00 [entrez] AID - S0039-6060(01)77150-4 [pii] AID - 10.1067/msy.2001.116411 [doi] PST - ppublish SO - Surgery. 2001 Aug;130(2):326-32. doi: 10.1067/msy.2001.116411.